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Sexual dysfunction affects both men and women, involving organic disorders, psycho-
logical problems, or both. Overall, the state of our knowledge is less advanced regarding 
female sexual physiology in comparison with male sexual function. Female sexual dys-
function has received little clinical and basic research attention and remains a largely 
untapped field in medicine. The epidemiology of female sexual dysfunction is poorly 
understood because relatively few studies have been done in community settings. In 
the United States, female sexual dysfunction has been estimated to affect 40% of women 
in the general population. Among the elderly, however, it has been reported that up 
to 87% of women complain of sexual dissatisfaction. Several studies have shown that 
the prevalence of female sexual arousal disorders correlates significantly with increas-
ing age. These studies have shown that sexual arousal and frequency of coitus in the 
female decreases with increasing age. The pathophysiology of female sexual dysfunc-
tion appears more complex than that of males, involving multidimensional hormonal, 
neurological, vascular, psychological, and interpersonal aspects. Organic female sex-
ual disorders may include a wide variety of vascular, neural, or neurovascular factors 
that lead to problems with libido, lubrication, and orgasm. However, the precise etiology 
and mechanistic pathways of age-related female sexual arousal disorders are yet to be 
determined. In the past two decades, some advances have been made in exploring the 
basic hemodynamics and neuroregulation of female sexual function and dysfunction 
in both animal models and in human studies. In this review, we summarize neural regu-
lation of sexual function and neurological causes of sexual dysfunction in women.
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ANATOMY OF THE FEMALE EXTERNAL 
GENITALS
The female genital organs consist of the labia majora, labia 
minora, clitoris, bulbs (of the vestibule), and vagina. While 
there are clearly many homologous structures in the male 
and female, the anatomy differs very significantly and 
should be described in its own right. Due to significant 
changes following menopause, many descriptions derived 
from cadaver dissection are inaccurate for younger and 
premenopausal women. 
　The vulva consists of the parts of the female genitals that 
are visible externally and include the labia majora, the la-
bia minora, the glans of the clitoris, and the vestibule of the 
vagina. The labia majora represent the cleft female homo-
logue to the male scrotum. They are two symmetrical folds 
of skin filled with fat, connective tissue, nerves and lym-
phatic vessels. The lateral surface is covered with variable 
amounts of coarse hair while the medial surface is hairless 
and contains a large number of sebaceous glands. The func-
tion of the labia majora is to protect and enclose the vaginal 
vestibule. The labia minora are thin, delicate folds of vas-
cular, fat-free, hairless skin located on each side of the vagi-
nal vestibule. The labia minora divide anteriorly to form 
the prepuce and frenulum of the clitoris. The glans of the 
clitoris is described below. The vestibule of the vagina is the 
space enclosed by the labia minora and leads into the vagi-
na itself. Anterior to the vestibule is the external urethral 
orifice and associated paraurethral (Skene’s) glands. 
Posteriorly, the vestibule receives the orifices of the greater Korean J Urol 2010;51:443-449
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vestibular (Bartholin’s) glands, which provide lubrication 
for the vestibule of the vagina and are homologues of the 
bulbourethral glands of the male.
THE CLITORIS
The clitoris is a small midline erectile body that is homolo-
gous to the male penis. It consists of a glans, body, and 
crura. The glans is easily visible at the superior junction 
of the labia minora. The body, consisting of paired corpora 
with an incomplete septum between them, is 1 to 2 cm wide 
and 2 to 4 cm long [1]. The crura, 5 to 9 cm in length, are 
attached to the ischial bone and covered by the ischioca-
vernosus muscle [1]. 
1. Structural support
Like the penis, the clitoris is attached to the pubis by speci-
alized connective tissue supports. The so-called suspensory 
ligament of the clitoris has both superficial and deep compo-
nents [2]. There is a superficial fibro-fatty ligament that ex-
tends from within the fatty tissue of the mons pubis to the 
body of the clitoris and into the labia majora. In addition, 
there is a deep component that originates on the symphysis 
pubis itself, extends to the body of the clitoris and then to 
the bulbs of the clitoris. The supporting structures of the 
clitoris thus appear to function less as suspensory liga-
ments and more as traction ligaments that transmit force 
from the labia majora, bulbs, and vaginal introitus to the 
clitoris. Some authors have suggested that the anterior 
vaginal wall acts to transmit forces generated during inter-
course to the clitoris [3].
2. Vascular supply
Blood supply to the body of the clitoris is supplied by paired 
pudendal arteries that course lateral to the urethra along 
the pelvic aspect of the anterior vaginal wall [1]. These ar-
teries give off the cavernous artery and the artery to the 
bulb. The body of the clitoris is composed of cavernous tis-
sue surrounded by tough tunica albuginea. However, the 
clitoris seems to lack the subalbugineal plexus character-
istic of the penis [4]. This finding suggests that, unlike the 
penis, the clitoris does not have a well developed outflow 
occlusion mechanism and becomes erect mainly through 
increased blood flow. 
3. Innervation and histochemistry
The glans of the clitoris forms a cap that sits on the ends 
of the corporal bodies and is richly innervated by sensory 
nerve endings [5]. The deep dorsal nerves perforate the 
glans on the dorsal aspect of its junction with the corporal 
bodies. Recent studies have confirmed that the dorsal 
nerve of the clitoris is relatively large (more than 2 mm in 
diameter) [1]. The cavernous nerve runs along with the cav-
ernous artery as it enters the bodies of the clitoris. Nerves 
containing neuronal nitric oxide synthase have been de-
tected in both the body and the glans of the human clitoris 
[6], suggesting that nitric oxide is involved in the control 
of clitoral smooth muscle tone. Nerve fibers containing vas-
oactive intestinal polypeptide (VIP), calcitonin gene-re-
lated peptide (CGRP) and substance P (SP) have also been 
described in human clitoral tissue [7,8].
THE BULBS OF THE VESTIBULE
The female urethra, like the bulbous portion of the male 
urethra, is surrounded laterally by erectile tissue called 
the vestibular bulbs in most anatomy texts. Recent ana-
tomic studies have shown that these erectile bodies are in-
timately related and lateral to the urethra rather than lat-
eral to the vestibule of the vagina [1]. They are not, as often 
depicted in anatomic texts, located within the labia minora. 
Superiorly, the bulbs continue as the pars intermedia and 
terminate as the glans of the clitoris [9]. Thus, the bulbs 
represent the cleft female homologue to the bulb of the ure-
thra in the male. The entire complex of spongy erectile tis-
sue consisting of bulbs, pars intermedia, and clitoral glans 
correspond to the corpus spongiosum of the male [9].
THE VAGINA
1. Structure
The vagina is a muscular sheath that connects the uterus 
and the external genitalia. It has both sexual and reproduc-
tive functions and this dual function is reflected in various 
aspects of its structure, especially its vascular supply, its 
sensory and motor innervation and its marked distensi-
bility. The wall of the vagina consists of an inner lining of 
stratified squamous epithelium, an intermediate layer of 
smooth muscle and an outer adventitial layer. The lining 
of the vagina is folded into numerous rugae which are re-
lated to its extreme distensibility. The vaginal entrance is 
closed by the bulbocavernosus muscle, a striated muscle.
2. Vascular supply
Corrosion studies of the rat vagina have shown that the vag-
inal epithelium is intimately related to a dense capillary 
network in the subepithelial layer [10]. This vascular net-
work may be related to the production of transudate during 
sexual arousal. Somewhat deeper, the loose submucosal 
layer contains a complex of numerous large veins and smooth 
muscle fibers that resemble cavernous tissue. The smooth 
muscle layer consists of an inner circular layer and a strong 
external longitudinal layer. The adventitial layer consists 
of connective tissue and a large plexus of blood vessels.
3. Innervation and histochemistry
The vagina has a complex innervation that is not well 
understood. The pelvic nerves appear to subserve sensa-
tion from the vagina while the pudendal nerve subserves 
sensation from the labia and clitoris [11]. Afferent nerves 
in the vagina appear to contain substance P in both animal 
[11,12] and human [13] tissue samples, although SP-con-
taining nerves appear to be sparse in the human vagina 
[13]. Nerves containing nitric oxide synthase (NOS) have Korean J Urol 2010;51:443-449
Neurologic Factors in Female Sexual Function and Dysfunction 445
been demonstrated in animal [14] and human vaginas [15]. 
Nerves containing CGRP, neuropeptide Y, VIP, and pep-
tide hisitidine-methionine (PHM) have also been found in 
the human vagina [15,16].
THE MECHANISM OF FEMALE SEXUAL AROUSAL 
RESPONSE
Female sexual arousal is a neurovascular phenomenon in-
volving nerve-regulated vascular reactions. Neurovascular 
interactions during sexual arousal lead to several hemody-
namic phases which affect simultaneously the clitoris, ves-
tibular bulbs, and labia minora as well as the vagina. In the 
resting phase, the vagina is a sheath containing a potential 
space with a minimal blood flow and very low oxygen ten-
sion in the wall [17,18]. The earliest detectable sign of sex-
ual arousal based on studies with experimental models is 
a significant increase in vaginal wall and clitoral blood flow 
[19]. There is a significant increase in clitoral cavernosal 
pressure as well [19]. With the onset of increased vaginal 
blood flow, production of vaginal transudate ensues [10, 
20]. A significant rise in tissue oxygen tension follows about 
20 seconds later which indicates increased inflow of arte-
rial blood. In humans, vaginal and labial oxygen tension 
increases from 4 to 8 times baseline during sexual stim-
ulation [17,18] and vaginal wall blood flow increases ap-
proximately threefold [21-23]. In humans, clitoral blood 
flow has been estimated to increase from 4 to 11 times base-
line during sexual stimulation [24]. The increased blood 
flow reaches a plateau phase during which vaginal fluid 
transudate production continues. The final or resolution 
phase is characterized by the slow return of blood flow to 
baseline values. In women, up to 20-30 minutes is required 
for vaginal oxygen tension to return to baseline [17].
　It is believed that the increase of clitoral intracavernosal 
and vaginal wall blood flow results in part from a decrease 
in vascular resistance and relaxation of clitoral cavernosal 
and vaginal wall tissues. The precise identity of the neuro-
transmitters that control vaginal blood flow is currently 
unknown. Atropine does not affect the pelvic nerve-stimu-
lated rise in vaginal blood flow in animals [19,25] or the rise 
in vaginal blood flow seen in human females [26]. This evi-
dence suggests that muscarinic neurotransmission is prob-
ably not involved. The ability of sildenafil to relax clitoral 
tissue and enhance nerve-stimulated vaginal blood flow has 
been reported [27,28]. This knowledge, of course, suggests 
the involvement of the NO-cyclic guanosine monophosphate 
(cGMP) pathway [27,29]. At the same time, it has been re-
ported that administration of VIP, either intravenously or 
by injection in the vaginal wall, increases vaginal blood flow 
and induces vaginal fluid production [10,30]. Peptide histi-
dine methionine (PHM) has effects similar to VIP but at lower 
potency [31]. Intravaginal prostaglandin E1 can also increase 
vaginal blood flow [32]. While some authors have stated 
that VIP is the primary neurotransmitter in the vaginal cir-
culation [21,22], much more research in this area is required. 
A study with a rabbit model has shown that systemic ad-
ministration of apomorphine had no effect on basal clitoral 
intracavernosal and vaginal wall blood flow while signi-
ficantly increasing blood inflow in these organs during 
nerve-stimulated vaginal and clitoral engorgement [32]. 
The precise mechanism by which apomorphine enhances 
nerve-stimulated but not basal clitoral intracavernosal 
and vaginal blood flow remains unknown. Apomorphine at 
concentrations of 0.1 mg/kg and 0.2 mg/kg was shown to be 
most effective in increasing nerve- stimulated clitoral in-
tracavernosal and vaginal wall blood flows in the rabbit 
[32]. This may suggest the involvement of dopaminergic re-
ceptors in regulating the hemodynamic mechanism of clito-
ral and vaginal engorgement. Vaginal blood flow appears 
to undergo phasic shifts in conjunction with rapid eye move-
ment (REM) sleep [33].
NEUROREGULATION OF FEMALE SEXUAL 
RESPONSE
1. Central mechanisms
Little is known about the central control of female sexual 
arousal. Sexual stimulation activates specific areas of the 
central nervous system such as the medial preoptic region, 
the anterior hypothalamic region, and the related limbic 
hippocampal structures. This stimulates transmission of 
signals via the parasympathetic and sympathetic pathways. 
The medial amygdala appears to be an important center 
that utilizes vasopressin as a central neurotransmitter 
[34]. Oxytocin is also clearly involved; oxytocin serum lev-
els measured before and after sexual stimulation in 12 
healthy women were significantly elevated [35]. Although 
intravenous apomorphine, a centrally acting dopaminergic 
agent, has been shown to cause increased peak clitoral and 
vaginal wall blood flow [32], the role of dopamine in female 
sexual behavior is not established. 
2. Spinal mechanisms
The mechanism of genital arousal and orgasm during sexual 
stimulation involve spinal cord reflexes that are mediated 
by genital afferents originating from the pudendal nerve. 
Interneurons mediating these reflexes are known to be in 
a column in the central portion of the spinal gray matter. 
The efferent arm of the spinal reflexes involves sympathetic, 
parasympathetic, and somatic activity [36]. Studies with 
a rabbit model have shown that electrical stimulation of the 
vaginal branch of the pelvic nerve increases clitoral intra-
cavernosal pressure and blood flow, vaginal wall pressure 
and blood flow, and vaginal length [19]. Afferent signaling 
during sexual stimulation enters the spinal cord in the sa-
cral segments, which is then transmitted to supraspinal 
sites via the spinothalamic and spinoreticular systems 
[36]. The spinothalamic pathway contains myelinated fi-
bers that end in the posterolateral nucleus of the thalamus, 
from which the signals are relayed to the medial thalamus. 
The precise reflex mechanisms of clitoral erection and vagi-
nal engorgement are yet to be studied. Korean J Urol 2010;51:443-449
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3. Peripheral mechanisms
The mechanism of vaginal engorgement during sexual 
arousal involves vasodilation and significant changes in 
vaginal tone. The vaginal tissue responds to sexual arousal 
by relaxing and lengthening [19]. Pelvic nerve-stimulated 
increased vaginal tone was abolished by atropine while 
vercuronium bromide, a striated muscle relaxant, pre-
vented the subsequent fall in vaginal tension [37]. These 
results suggest that vaginal contraction may be under chol-
inergic control while vaginal lengthening or enlargement 
may relate to striated muscle contraction. How striated 
muscle contraction produces a decrease in vaginal pres-
sure is unclear. It has been shown in humans that the distal 
part of the vagina contains more nerve fibers compared to 
the proximal part; likewise, the anterior vaginal wall is 
more densely innervated than the posterior wall [38]. 
Embryological origins of the proximal and distal vagina are 
also suggested to be different. The distal two-thirds of the 
vagina is suggested to be a derivative of the urogenital si-
nus whereas the proximal part is thought to originate from 
the uterovaginal primordium [39].
　In the rabbit, stimulation of the vaginal branch of the pel-
vic nerve results in lengthening and dilation of the vagina 
that further leads to a lowering of vaginal luminal pressure 
and an increase in intravaginal wall pressure [19]. In rats, 
stimulation of the pelvic nerve causes a biphasic response 
in vaginal wall tension [37]. There is a rapid, short-lived 
increase in vaginal wall tension followed by a fall in tension 
to below the baseline value which is indicative of vaginal 
wall relaxation [19,37].
　Organ bath studies with the rabbit vaginal tissue have 
shown that at baseline tension, electrical field stimulation 
(EFS) causes a biphasic contraction and relaxation re-
sponse [40]. The alpha-2 adrenoceptor blocker yohimbine 
and the beta blocker propranolol were found to have little 
effect on vaginal tissue contraction in response to EFS and 
norepinephrine. Prazosin seemed to be significantly effec-
tive in inhibiting these contractile responses, suggesting 
that vaginal tissue contraction may be primarily mediated 
by the alpha-1 adrenoceptor [40]. Relaxation of the vaginal 
tissue appears to involve a non-adrenergic non-cholinergic 
(NANC) mechanism. The nature of the vaginal NANC neu-
rotransmission remains controversial. The rabbit vaginal 
tissue relaxes after exposure to acetylcholine (Ach), vaso-
active intestinal polypeptide (VIP), papaverine, and the ni-
tric oxide (NO) donor nitroprusside in a concentration de-
pendent manner [40]. VIP was found to be more effective 
in relaxing the vaginal tissue than the clitoral tissue [40]. 
The NO precursor L-arginine and the nitric oxide synthase 
inhibitor nitro-L-arginine (L-NNA) appeared to have little 
effect on vaginal tissue relaxation. Another study, how-
ever, found that NNA significantly inhibits the electri-
cally-stimulated relaxation of rabbit vaginal tissue [41]. 
The authors performed immunohistochemical staining, 
which revealed marked eNOS and nNOS in the rabbit 
vagina. It was also found that estrogen treatment down-
regulates eNOS and nNOS expression in the rabbit vagina 
[41]. A VIP receptor antagonist has been shown to sig-
nificantly increase the relaxation response to VIP while 
having little effect on EFS-induced relaxation of the vagi-
nal tissue [40]. It has also been shown that nerve fibers in 
the vagina that run subepithelium and near the vascular 
bed are rich in VIP-immunoreactivity [42]. Human vaginal 
nerve fibers contain not only VIP and NOS but neuro-
peptide Y, CGMP, CGRP, and substance P as well [15]. 
Immunohistochemical staining has revealed the ex-
pression of five functional domains of the VIP precursor 
throughout the female human genital tract in neuronal ele-
ments closely related to the epithelial lining, perivascular 
tissue, and non-vascular smooth muscle [43].
　Clitoral and penile smooth muscle appears to share a 
similar neuroregulatory mechanism. As in the human pe-
nis, immunohistochemical staining of human clitoral cav-
ernosal tissue has revealed NOS subtype expression, sug-
gesting the involvement of NO in the regulation of clitoral 
smooth muscle contractility and the development of clito-
ral engorgement [41]. Organ bath studies with the rabbit 
clitoral cavernosal tissue have shown that contraction of 
the clitoral tissue is primarily mediated by alpha-1 adreno-
ceptor [40]. Acetylcholine, VIP, papaverine, and the NO do-
nor nitroprusside produce concentration-dependent relax-
ation in clitoral tissue as in penile tissue [40]. L-arginine 
significantly increases and NNA inhibits the clitoral relax-
ation to EFS and Ach, suggesting that endothelium-de-
pendent and neurogenic relaxation of clitoral tissue may 
be mediated by NO. Another study showed that clitoral 
smooth muscle relaxation is enhanced by sildenafil, sug-
gesting involvement of cGMP [27]. Angiotensin II has been 
shown to be a potent constrictor of rabbit clitoral smooth 
muscle in an organ bath. The clitoris has been shown to 
have angiotensin II receptors of the AT1 variety [44]. 
NEUROGENIC SEXUAL DYSFUNCTION IN WOMEN
Female sexual dysfunction has been categorized into prob-
lems with desire, arousal, orgasm, and pain [45-48]. Sexual 
desire disorders are sub-classified into hypoactive sexual 
desire disorders and sexual aversion disorders. Hypoactive 
sexual desire disorder is defined as persistent or recurrent 
lack of or absence of sexual fantasies and thoughts or desire 
for sexual activity. Sexual aversion disorder is a persistent 
or recurring fear, aversion to, and avoidance of sexual con-
tact with a partner. Sexual arousal disorder is defined as 
the persistent or recurrent inability to achieve or maintain 
sexual excitement. This may be expressed as lack of excite-
ment, lack of lubrication, lack of vaginal and clitoral en-
gorgement, or lack of expression of other somatic responses. 
Orgasmic disorder is defined as the persistent or recurrent 
inability to achieve orgasm with sexual stimulation and 
arousal. Sexual pain disorders are sub-classified into dys-
pareunia, vaginismus, and other sexual pain disorders. 
Dyspareunia is defined as recurrent or persistent genital 
pain during sexual intercourse. Vaginismus is the recurrent 
or persistent involuntary spasm of outer vaginal muscu-Korean J Urol 2010;51:443-449
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lature, which makes vaginal penetration difficult. Other 
sexual pain disorders include noncoital sexual pain, which 
is defined as recurrent or persistent genital pain caused by 
noncoital sexual stimulation. All types of sexual desire dis-
orders are likely to lead to personal distress. Each category 
of female sexual dysfunction is divided to subtypes: chronic 
versus acquired, generalized versus situational, and or-
ganic versus psychogenic. 
　In contrast to the male, the pathophysiology of female 
sexual dysfunction is not easily categorized as vasculo-
genic, neurologic, or hormonal. Rather, it appears to in-
volve multidimensional biologic, psychologic, and inter-
personal aspects [49,50]. Sexual dysfunction in women cor-
relates with age and with educational level [49]. The fre-
quency of these sexual problems increases as menopause 
approaches and reaches a peak in the postmenopausal 
years [49,50].
　Neurologic disorders are known to be associated with 
sexual dysfunction both in women and men. The role of neuro-
logic factors in female sexual dysfunction, however, remains 
somewhat unexplored and may be undiagnosed. Many neu-
rologic disorders, including autonomic and peripheral neu-
ropathy, spinal cord injury, diabetic neuropathy, multiple 
sclerosis, and lumbar radiculopathy are likely to interfere 
with the neurophysiology of the female genital organs and 
lead to their dysfunction. It is believed that any neural le-
sion, central or peripheral, can interfere with the sensory 
and somatic component of the female genitals and lead to 
dysfunction. Dysfunction of the sensory fibers may inter-
fere with the afferent signaling and sensory modalities that 
are quite important in female sexual response. 
CENTRAL CAUSES OF FEMALE SEXUAL 
DYSFUNCTION
Central regulation of female sexual response has been ex-
plored to some extent. Central lesions are likely to interfere 
with female sexual physiology and lead to dysfunction. The 
precise mechanism by which central lesions affect female 
sexual function is yet to be determined. In general, it is be-
lieved that any central lesion would alter the efferent and 
afferent pathways of female sexual response leading to 
dysfunction. 
SPINAL CAUSES 
The relationship between spinal cord lesions and female 
sexual dysfunction has been frequently reported. In women, 
spinal cord injury may be associated with orgasmic and/or 
lubrication failure [51]. Arousal may be secondary to audio-
visual stimuli, fantasy, or genital stimulation. In women 
with complete suprasacral spinal cord injury above T6, audio-
visual stimuli fail to cause any change in vaginal pulse am-
plitude [52]. However, in women with preservation of sensory 
function in T11-L2 dermatomes, psychogenically-mediated 
genital vasocongestion is possible [53]. This suggests that, 
as in the male, the sympathetic outflow is an important 
pathway for psychogenic genital response in the female.
　Women with complete or incomplete suprasacral injury 
can achieve reflex genital response by manual stimulation 
but not when there is involvement of the sacral segments 
[54]. Orgasm is less likely in women with spinal cord injury 
and correlates poorly with the type of injury [53].
THE ROLE OF DIABETIC NEUROPATHY
Diabetes affects sexual function in both women and men. 
Diabetes mellitus, which is known to cause erectile dys-
function in men, may interfere with sexual function in 
women [55-58]. This issue, however, has been poorly inves-
tigated and it is unclear how diabetes leads to sexual dis-
orders in women [59]. Female sexual dysfunction can be re-
garded as a silent complication of diabetes mellitus. Jensen 
studied the sexual function of 80 diabetic women and 40 
non-diabetic women [58]. A significantly larger number of 
diabetic women (11 percent) complained of lack of orgasm 
compared with non-diabetic women (7.5 percent). A much 
greater number of diabetic women (24 percent) reported 
difficulty in achieving vaginal lubrication compared with 
non-diabetic women (8 percent). Within the diabetic group, 
the incidence of sexual dysfunction was much greater in 
women with diabetes-related peripheral neuropathy (44 
percent) than in diabetic women without neuropathy. 
Another study showed that peripheral neuropathy closely 
correlates with sexual dysfunction in diabetic women [60]. 
Other studies have reported increased problems with vagi-
nal lubrication in diabetic women [57,61]. Using vaginal 
photoplethysmographic measures of capillary engorge-
ment, it has been shown that diabetic women demonstrate 
significantly less physiological arousal to erotic stimuli 
than controls, even though their subjective responses were 
comparable [62]. Biothesiometric examination has re-
vealed that the sensation of the vaginal introitus, labium 
minora, and clitoris were markedly deteriorated in dia-
betic women compared with non-diabetic women [63]. 
　Studies with a rat model of streptozotocin-induced dia-
betes have shown that diabetes impairs the relaxation re-
sponses of the vaginal tissue to EFS, to NO donors, and to 
calcitonin gene-related peptide (CGRP) [37]. It was also 
shown that diabetes impairs the contractile response of 
vaginal tissue to norepinephrine and to EFS. In the latter 
study, both the NO donors and CGRP inhibited EFS-in-
duced contractions in diabetic and non-diabetic strips but 
the inhibition was found to be significantly lower in the dia-
betic group [37].
PERIPHERAL NEURAL FACTORS 
Peripheral neurological disorders are known to be asso-
ciated with sexual dysfunction in both women and men. 
Peripheral neuropathy is a common cause of erectile dys-
function but there is little relevant literature in females. 
Clitoral neuropathy has been observed to cause sexual dys-
function [64]. In a test of female genital pressure and touch Korean J Urol 2010;51:443-449
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sensation, 32 neurologically intact women and 5 neuro-
logically impaired women were tested [65]. A clear associa-
tion was found between reduced vulvar sensitivity to pres-
sure/touch and estrogen deficiency, sexual dysfunction, 
and neurologic impairment [65]. Postmenopausal and hy-
poestrogenic women had significantly reduced sensitivity 
to pressure/touch compared with premenopausal and nor-
moestrogenic women, respectively [65]. 
　Pudendal neuropathy as a complication of orthopedic 
surgery involving traction has been shown to induce sexual 
dysfunction [66]. This condition was found to be associated 
with signs of pudendal neurodegeneration and abnormal 
somatosensory evoked potentials of the pudendal nerve. 
Stretch neuropathy of the internal pudendal nerve and per-
ineal nerve motor latency have been reported due to stretch 
injury of the pelvic musculature when the pelvic floor dia-
phragm is weak [67]. Perineal stretch neuropathy was 
found to closely correlate with the incidence of sexual dys-
function in women [67].
PSYCHOLOGICAL FACTORS 
In women, psychological factors (history of sexual abuse, 
depression, anxiety, obsessive compulsive disorders), soci-
ocultural issues (beliefs regarding sexual activity), and in-
terpersonal issues (partner availability, partner function, 
relationship with partner, communication with partner) 
affect sexual function in all age groups [50,68]. With aging, 
additional psychological stresses may come to the fore, par-
ticularly loss of fertility, interruption of the menstrual cy-
cle, and the start of postmenstrual changes. Recently, how-
ever, there has been a large cultural shift with respect to 
the negative implications of aging and menopause. The 
“baby boom” generation, in contrast to their mothers and 
grandmothers, believe that aging need not necessarily 
cause asexuality, poor health, and loss of productivity. 
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